Recently, leading orthopedic medical device giant -
) launched its full range of ankle replacement system and
instrument system at the 2013 American Academy of Orthopaedic
Surgeons annual meeting in Chicago. This innovative ankle
replacement product, known as Trabecular Metal Total Ankle
replacement and instrument system, designed to repair disorder,
reduce pain, and preserve the flexion and extension movement of
the ankle joint is likely to be a big relief for the orthopedic
patients in regaining mobility.
The company is optimistic about this new invention, which is
expected to procure better results even amid the challenging US
extremity market. According to Zimmer, this ankle replacement and
instrument system is the first of its kind ankle replacement
system that combines cutting-edge techniques of knee and hip
replacement with total ankle arthroplasty, including advanced
bearing materials and customized shapes and sizes.
Further, Zimmer encouragingly noted that the modular
articular surface of this new product is built with Prolong
Highly Crosslinked Polyethylene, which has an excellent history
of more than 10 years as a bearing material in total knee
arthroplasty. In addition, as the system is implanted
through a lateral surgical approach, it provides the full view of
the ankle joint leading to accurate implantation.
Zimmer is making continuous efforts to strengthen its pipeline
with the launch of new products under the reconstructive implant
division. Moreover, the ongoing shift in demand to premium
products, such as Prolongand Vivacit-EHighly Crosslinked
Polyethylene, Trabecular MetalTM Technology products, high-flex
knees, porous hip stems and the introduction of patient specific
devices is expected to continue to positively affect sales
growth. Along with the focus on driving Reconstructive and
emerging businesses, Zimmer is exploring opportunities to expand
its reach into early intervention products.
The company should benefit from the favorable long-term trends
that point toward sustained growth driven by obesity, wear and
tear of joints from more active lifestyles, growth in emerging
markets, new material technologies, advances in surgical
techniques and proven clinical benefits of joint replacement
More importantly, the percentage of population over age 65 in
the U.S., Europe, Japan and other regions is expected to nearly
double by the year 2030. In the U.S., the oldest baby boomers are
now pushing retirement age. We believe that Zimmer is benefiting
from this aging demography since knee and hip joints tend to wear
out with age and therefore require replacement.
However, the intense competition in the orthopedic market and
pricing pressure remain areas of concern. The company faces tough
competition from players such as
Zimmer currently carries a Zacks Rank #3 (Hold). However,
other medical device stocks worth a look are
). Both these stocks carry a Zacks Rank #1 (Strong Buy).
CYTOKINETCS INC (CYTK): Free Stock Analysis
GIVEN IMAGING (GIVN): Free Stock Analysis
STRYKER CORP (SYK): Free Stock Analysis
ZIMMER HOLDINGS (ZMH): Free Stock Analysis
To read this article on Zacks.com click here.